Consistent with the observations in cultured lung cancer cells, the administration of miR-26a inhibitors caused increased PTPN13 protein levels and decreased phospho-Src levels in NSCLC xenograft tumors (Figure 6D). The gene discussed is PTPN13; the disease is non-small cell lung carcinoma.